Merck & Co., Inc.
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck Non-GAAP Diluted Earnings per Share by Quarter
Non-GAAP Diluted Earnings per Share ($) ($)
Merck Non-GAAP Diluted Earnings per Share: -$0.13 in Q2 2026, down 106.1% from a year earlier.
Where the Q2 2026 figure comes from
“|| Loss per Common Share Assuming Dilution (4) | $ | (0.54 | ) | (0.35 | ) | (0.12 | ) | 0.06 | (0.41 | ) | $ | (0.13 | )”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Supplemental Table 2a (GAAP to Non-GAAP Reconciliation).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up non-GAAP Diluted Earnings per Share
- Non-GAAP Net Income Attributable to Merck & Co., Inc. ($M)-1,005 · Q2 2026
- Non-GAAP Income Before Taxes ($M)550 · Q2 2026
- Non-GAAP Cost of Sales ($M)3,144 · Q2 2026
- Non-GAAP Selling, General and Administrative (SG&A) Expense ($M)2,887 · Q2 2026
- Non-GAAP Research and Development (R&D) Expense ($M)9,736 · Q2 2026
- Non-GAAP Other (Income) Expense, Net ($M)290 · Q2 2026
- Non-GAAP Income Tax Provision ($M)882 · Q2 2026
- Non-GAAP Effective Income Tax Rate (%)160.3% · Q2 2026
- GAAP Effective Income Tax Rate (%)-95.9% · Q2 2026
Cite this data
StockData. (2026). Merck Non-GAAP Diluted Earnings per Share ($), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/nongaap-eps
See every metric in the Merck KPI table. Data updated Oct 26, 2026.